Aasta jooksul kahekordistunud riisi hind ei taha kuidagi näidata jahtumise märke. Maailma suurimaks riisi importijaks on Filipiinid, mis teatas järjekordsest suurekoguselisest riisi ostusoovist. Samal ajal on Hiina, Egiptus, Vietnam ja India oma elanike huvides riisi eksporti piiramas. Pakkumise poole pealt on kitsas käes, seega ei pruugi ka praegune hind jääda tipuks. Kuna riis on põhitoiduks poolele maailma rahvastikust, on tegemist üsna terava olukorraga, mis kutsub esile inimeste proteste ning lisab survet inflatsioonile.
Seoses Charles Schwabi (SCHW) kahe võlakirjafondi langusega on juurde lisandunud põhjuseid, et ettevõtte aktsiaid müüa. Need kaks fondi on YieldPlus Fund ja Short-Term Bond Market Fund ning mõlema fondi liikumine on ära toodud allolevatel graafikutel:
Kuigi ebalikviidsete varade müümise järel tekkinud kukkumine võib suures osas möödas olla ning fondid kaubelda oma põhjade lähedal (kahe fondi omavahelisest seosest saab täpsemalt lugeda siit), siis taoline olukord koos negatiivse meediakajastusega tekitab usaldamatust kogu ettevõtte suhtes. Uusi kliente ei paista kusagilt, nüüd on oodata, et ka olemasolevad hakkavad lahkuma.
Teema ise on juba suhteliselt vana ning seepärast sai SCHW märtsi lõpus omale kaela ka kohtuasja, kus ettevõtet süüdistatakse faktide varjamises. Ainukeseks küsimuseks jääb, kas taoline olukord ja klientide varade vähenemine on alles hoogu kogumas. Kuigi märtsi statistikat veel avaldatud ei ole, võib sealt varade mahu (kuid ka kauplemistulude) osas oodata pigem halba üllatust.
Veebruaris jäid klientide varad jaanuariga samale tasemele, jaanuaris aga vähenesid varad 3% mom. Märtsis ootaks oluliselt suuremat langust ning eelpool toodud graafikud aitavad sellele ka kaasa. Haldustasud vähenevad, uut raha peale ei tule, vana lahkub - probleeme jätkub.
Turg aga paistab arvavat, et enamus muredest on seljataga ning SCHW-d nähakse jätkuvalt kui potentsiaalselt turuosa võitjat ja head pikaajalist investeerimisideed. Nagu varemgi öeldud, siis viimasega võib isegi nõus olla, kuid lühiajaliselt ei paista ühtegi präänikut ees ootavat.
Notable Callist:
Morgan Keegan, one of the best research houses on the Street is downgrading Apple (NASDAQ:AAPL) to Underperform from Mkt Perform.
Notablecalls: About time! I was all over AAPL when the stock was 35 pts lower. I now feel it has gone too far too fast. Needs to be at least 10 pts lower. The problems with iPhone in Europe should be weighing on the stock. Read what uber-analyst Tero Kuittinen had to say about European iPhone demand over at Realmoney.
Teatavasti on Euroopas iPhone'i hindasid langetatud ning Saksamaal T-Mobile'i võrgus saab telefoni kätte isegi EUR 99 eest (kampaania ise kestab 30. juunini - kas väike vihje?). Kuigi tõenäoliselt on eesmärgiks poed enne 3G toega iPhone'i tulekut tühjaks müüa, on senine müük Euroopas olnud pigem pettumuseks. Kui USAs on jätkuvalt järjekorrad, siis Euroopas on eufooria möödunud kiiremini. Selge on, et marginaalidele sellised hinnalangetused head ei tähenda, lisaks viitab pessimistlikumale tulevikule ka see eilne teade:
CNET News.com reports the co has cut its 2008 flash memory orders by $200 mln, according to iSuppli, setting up a down year for flash vendors. After crunching the numbers, iSuppli expects Apple to spend $1.4 bln on flash this year for iPods and iPhones, up 12% from $1.2 bln last year. But the analyst co, and the flash memory industry, had been expecting much more purchasing out of Apple, at least $1.6 bln.
Pisike parandus: Iphone saab 99€ eest.
ericom, tänud, panin õigeks.
Fannie Mae (FNM) ja Freddie Mac (FRE) on mõlemad eelturul 3% plussis, põhjuseks Lehmani soovituse tõtsmine "overweight" tasemele.
Ja FMD on 30% all, põhjuseks tema võlakirjade kindlustaja TERI ch 11.
ja siingi foorumites haibitud NTRI on üleval eelturul
Co issues upside guidance for Q1 (Mar), sees Q1 (Mar) revs of $216 mln vs. $203.46 mln First Call consensus
Co issues upside guidance for Q1 (Mar), sees Q1 (Mar) revs of $216 mln vs. $203.46 mln First Call consensus
Ahjaa, FNM ja FRE võivad olla head short kandidaadid sellelt tasemelt.. esiteks turg on s*tt täna, teiseks FMD uudis ei aita sentimendile kaasa ja kolmandaks on Goldman negatiivselt väljas.
Kui SPX täna murrab allapoole 1370 taset, võib tulla kobe languspäev.
see on FMD'le kõva laks
sellest august välja ronimine võtab veel palju aega
sellest august välja ronimine võtab veel palju aega
mis seis selle FNDT-ga siis on?
Citi on CTIA konverentsi raames kohtumas mitmete telekomiettevõtetega, 3G upgrarde'de tulemusena soovitatakse osta "võrgumastide" haldajate aktsiaid:
Aggressive 3G upgrades by TMobileUSA, with 5k of the 7k planned upgrades already completed during 1Q,coupled with a 1H/08 push by AT&T for its pending launch of the 3G iPhone,should help 1H/08 tower fundamentals. Still prefer Buy-rated AMT.
AMT-d siiski ummisjalu ostma ei tasu joosta, hinnatase tundub positiivsete stsenaariumitega juba arvestavat.
Briefingu andmetel: Jaapan on seisukohal, et USA pangad vajavad lisakapitali.
Globe and Mail reports the Bank of Japan said Washington may have to use public funds to bail out U.S. banks hit by the credit crisis as Tokyo joined European calls for the Group of Seven states to work together calm financial mkts. The collapse of a mortgage bubble has so starved some U.S. banks of capital that the govt may have to step in if private investment does not work, said Masaaki Shirakawa, deputy governor and acting head of the central bank said before a G7 meeting this week. "First of all, it should be efforts by the private sector. But if the efforts by the private sector are not enough, a public capital fund injection, among various options, may become necessary," Mr. Shirakawa, the government nominee to head the BOJ, told a parliamentary hearing considering his candidacy. European finance officials have been stepping up calls for G7 nations to act together to protect the global economy and prevent another credit crisis from infecting mkts.
Videod.
Mr Mortgage Exposes Wells Fargo's Toxic Waste
Mr Mortgage - BIG BANKS HOME EQUITY EXPOSURE REVEALED
Mr Mortgage Exposes Wells Fargo's Toxic Waste
Mr Mortgage - BIG BANKS HOME EQUITY EXPOSURE REVEALED
NTRI-t oli veel hiljuti päris omajagu käes. Väga visalt liikus ülespoole. Eile sai viimanegi kogus ära müüdud :(
Saksamaa DAX -1.11%
Prantsusmaa CAC 40 -1.12%
Inglismaa FTSE 100 -0.82%
Hispaania IBEX -1.31%
Venemaa MICEX -0.74%
Poola WIG -1.22%
Aasia turud:
Jaapani Nikkei 225 -1.76%
Hong Kongi Hang Seng -1.09%
Hiina Shanghai A (kodumaine) +0.36%
Hiina Shanghai B (välismaine) +1.00%
Lõuna-Korea Kosdaq -0.35%
Tai Set +0.25%
India Sensex -1.08%
Market Still Looks Good, Even With Reversal
By Rev Shark
RealMoney.com Contributor
4/7/2008 4:34 PM EDT
Although the indices closed around flat on the day, there were a lot of big reversals in some of the recent momentum favorites. Solar energy, steels and agricultural chemicals all opened very hot and then saw selling pressure most of the day. Given how far some of the hot groups have moved recently, some profit-taking was bound to kick in, especially when the emotions were running so high this morning.
Even with some rather dramatic reversals, the market continues to look pretty good technically. We are holding up, even though we are somewhat extended at this point. However, I'd like to see better volume. I'm concerned that it has been so light, as this market has run over the last couple weeks. We are not seeing big institutional accumulation, and that makes the underlying support a bit uncertain. At some point, to make this move convincing, we need better volume.
Despite some negatives under the surface, the bulls continue to have the benefit of the doubt because they are holding up so well. We've had plenty of good excuses for some profit-taking to accelerate, and it just hasn't happened. There seem to be some underlying support among underinvested bulls and that holds the seeds of further upside.
-----------------------------
Ülespoole avanevad:
In reaction to strong earnings/guidance: NTRI +16.5%, NUAN +3.1%, VRSN +2.0% (also Brian Robins named acting CEO), CHTT +1.8%, CHINA +1.4%... Other news: RGEN +22.7% (announces settlement with Bristol-Myers Squibb in Orencia lawsuit), AGEN +22.3% (announces that the Russian Ministry of Public Health has issued a registration certificate for the use of Oncophage in the treatment of kidney cancer patients at intermediate risk for disease recurrence), VRNM +4.9% (announces commencement of start-up phase at its demonstration-scale cellulosic ethanol plant), ANSV +4.1% (announces that a pivotal Phase 3 clinical trial evaluating Adlea is underway), ATAC +3.5% (will replace MESA in the S&P SmallCap 600 after the close on 4/9), ISIS +3.0% (Bristol-Myers Squibb selects ISIS drug targeting PCSK9 as development candidate for prevention and treatment of cardiovascular disease), TIN +3.0% (Cramer makes positive comments on MadMoney), PXD +2.8% (raises long-term production growth target to 14+% and increases net resource potential by 1.1 bln barrels oil equivalent), FMX +2.2% (Cramer makes positive comments on MadMoney), INSU +1.9% (completes review of strategic options; determines to execute business plan and hire new CEO), ELN +1.9% (still checking), CRXL +1.8% (announces a non-exclusive STAR research license agreement with Celltrion for the production of recombinant proteins), ITG +1.5% (says March 2008 US trading volume was 4.6 billion shares), UN +1.1% (still checking)... Analyst upgrades: FNM +2.8% (upgraded to Overweight at Lehman), PSUN +2.7% (upgraded to Outperform at Wachovia), FRE +2.6% (upgraded to Overweight at Lehman), IVAC +2.1% (upgraded to Buy at Brean Murray), NYX +1.6% (upgraded to Buy at tier 1 firm), AXP +1.6% (upgraded to Buy at tier 1 firm), NVS +1.3% (upgraded to Neutral at HSBC).
Allapoole avanevad:
In reaction to weak earnings/guidance: CBBO -7.4%, SCUR -7.1%, NVLS -4.6%, LDK -2.5% (also announces proposed offering of us$300 million senior convertible notes), AMD -2.2%, AUO -2.1%, AA -1.9%, MNTG -1.4%... Select financial names showing weakness: BCS -3.8%, LYG -3.4%, CIT -3.3%, STD -1.8%, HBC -1.1%, DB -1.0%... Other news: GRO -46.1% (announces resignation of COO and retracts prior guidance), FMD -31.8% (makes statement on TERI's petition for reorganization under Chapter 11; says is analyzing the implications of this filing), REXX -8.1% (files S-1 relating to 8 mln share offering by co selling 4 mln shares of common stock and the selling stockholders are selling 4 mln shares of common stock), MWE -5.6% (announces public offering of 5 mln common units at $32.44/unit), ASML -5.6% (down in sympathy with AMD), WM -5.3% (finalizing capital injection plan and downgraded to Underperform at Keefe Bruyette), SIRF -5.0% (discloses CFO resignation), ENDP -3.0% (announced that it has notified the FDA of the withdrawal of the sNDA without prejudice for FROVA), DEPO -2.0% (settles patent litigation against IVAX and as stated that it intends to return the rights to Chronogesic licensed from DURECT), RTP -1.7% and BHP -1.5% (Rio Tinto can go it alone, CEO says - Globe and Mail)... Analyst downgrades: IFX -6.5% (downgraded to Neutral at Credit Suisse), GRMN -5.1% (downgraded to Hold at Soleil), MI -4.2% (downgraded to Sell at tier 1 firm), JBL -4.0% (Hearing downgraded to Neutral from Buy at tier 1 firm), FLS -3.9% (downgraded to Neutral at Baird), AZN -2.9% (downgraded to Neutral at tier 1 firm), NITE -2.4% (hearing downgraded to Neutral at tier 1 firm), CNK -2.2% (downgraded to Neutral at JPMorgan).
By Rev Shark
RealMoney.com Contributor
4/7/2008 4:34 PM EDT
Although the indices closed around flat on the day, there were a lot of big reversals in some of the recent momentum favorites. Solar energy, steels and agricultural chemicals all opened very hot and then saw selling pressure most of the day. Given how far some of the hot groups have moved recently, some profit-taking was bound to kick in, especially when the emotions were running so high this morning.
Even with some rather dramatic reversals, the market continues to look pretty good technically. We are holding up, even though we are somewhat extended at this point. However, I'd like to see better volume. I'm concerned that it has been so light, as this market has run over the last couple weeks. We are not seeing big institutional accumulation, and that makes the underlying support a bit uncertain. At some point, to make this move convincing, we need better volume.
Despite some negatives under the surface, the bulls continue to have the benefit of the doubt because they are holding up so well. We've had plenty of good excuses for some profit-taking to accelerate, and it just hasn't happened. There seem to be some underlying support among underinvested bulls and that holds the seeds of further upside.
-----------------------------
Ülespoole avanevad:
In reaction to strong earnings/guidance: NTRI +16.5%, NUAN +3.1%, VRSN +2.0% (also Brian Robins named acting CEO), CHTT +1.8%, CHINA +1.4%... Other news: RGEN +22.7% (announces settlement with Bristol-Myers Squibb in Orencia lawsuit), AGEN +22.3% (announces that the Russian Ministry of Public Health has issued a registration certificate for the use of Oncophage in the treatment of kidney cancer patients at intermediate risk for disease recurrence), VRNM +4.9% (announces commencement of start-up phase at its demonstration-scale cellulosic ethanol plant), ANSV +4.1% (announces that a pivotal Phase 3 clinical trial evaluating Adlea is underway), ATAC +3.5% (will replace MESA in the S&P SmallCap 600 after the close on 4/9), ISIS +3.0% (Bristol-Myers Squibb selects ISIS drug targeting PCSK9 as development candidate for prevention and treatment of cardiovascular disease), TIN +3.0% (Cramer makes positive comments on MadMoney), PXD +2.8% (raises long-term production growth target to 14+% and increases net resource potential by 1.1 bln barrels oil equivalent), FMX +2.2% (Cramer makes positive comments on MadMoney), INSU +1.9% (completes review of strategic options; determines to execute business plan and hire new CEO), ELN +1.9% (still checking), CRXL +1.8% (announces a non-exclusive STAR research license agreement with Celltrion for the production of recombinant proteins), ITG +1.5% (says March 2008 US trading volume was 4.6 billion shares), UN +1.1% (still checking)... Analyst upgrades: FNM +2.8% (upgraded to Overweight at Lehman), PSUN +2.7% (upgraded to Outperform at Wachovia), FRE +2.6% (upgraded to Overweight at Lehman), IVAC +2.1% (upgraded to Buy at Brean Murray), NYX +1.6% (upgraded to Buy at tier 1 firm), AXP +1.6% (upgraded to Buy at tier 1 firm), NVS +1.3% (upgraded to Neutral at HSBC).
Allapoole avanevad:
In reaction to weak earnings/guidance: CBBO -7.4%, SCUR -7.1%, NVLS -4.6%, LDK -2.5% (also announces proposed offering of us$300 million senior convertible notes), AMD -2.2%, AUO -2.1%, AA -1.9%, MNTG -1.4%... Select financial names showing weakness: BCS -3.8%, LYG -3.4%, CIT -3.3%, STD -1.8%, HBC -1.1%, DB -1.0%... Other news: GRO -46.1% (announces resignation of COO and retracts prior guidance), FMD -31.8% (makes statement on TERI's petition for reorganization under Chapter 11; says is analyzing the implications of this filing), REXX -8.1% (files S-1 relating to 8 mln share offering by co selling 4 mln shares of common stock and the selling stockholders are selling 4 mln shares of common stock), MWE -5.6% (announces public offering of 5 mln common units at $32.44/unit), ASML -5.6% (down in sympathy with AMD), WM -5.3% (finalizing capital injection plan and downgraded to Underperform at Keefe Bruyette), SIRF -5.0% (discloses CFO resignation), ENDP -3.0% (announced that it has notified the FDA of the withdrawal of the sNDA without prejudice for FROVA), DEPO -2.0% (settles patent litigation against IVAX and as stated that it intends to return the rights to Chronogesic licensed from DURECT), RTP -1.7% and BHP -1.5% (Rio Tinto can go it alone, CEO says - Globe and Mail)... Analyst downgrades: IFX -6.5% (downgraded to Neutral at Credit Suisse), GRMN -5.1% (downgraded to Hold at Soleil), MI -4.2% (downgraded to Sell at tier 1 firm), JBL -4.0% (Hearing downgraded to Neutral from Buy at tier 1 firm), FLS -3.9% (downgraded to Neutral at Baird), AZN -2.9% (downgraded to Neutral at tier 1 firm), NITE -2.4% (hearing downgraded to Neutral at tier 1 firm), CNK -2.2% (downgraded to Neutral at JPMorgan).
Washington Mutual (WM) Raising $7 Billion Anchored by a TPG Capital Investment, WM sees Q1 EPS ($1.40) vs consensus of ($0.49), cuts dividend.
Aktsia hetkel eelturul -11%.
Aktsia hetkel eelturul -11%.
Ja FRE - FNM enamvähem nullis. Paras aeg kinni panna, ei tasu ahneks minna.